Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thyroid hormone therapy in differentiated thyroid cancer.
Grani G, Ramundo V, Verrienti A, Sponziello M, Durante C. Grani G, et al. Among authors: durante c. Endocrine. 2019 Oct;66(1):43-50. doi: 10.1007/s12020-019-02051-3. Epub 2019 Oct 15. Endocrine. 2019. PMID: 31617165 Review.
Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
Montesano T, Durante C, Attard M, Crocetti U, Meringolo D, Bruno R, Tumino S, Rubello D, Al-Nahhas A, Colandrea M, Maranghi M, Travascio L, Ronga G, Torlontano M. Montesano T, et al. Among authors: durante c. Biomed Pharmacother. 2007 Sep;61(8):468-71. doi: 10.1016/j.biopha.2007.04.001. Epub 2007 May 22. Biomed Pharmacother. 2007. PMID: 17553654
Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients.
Torlontano M, Durante C, Torrente I, Crocetti U, Augello G, Ronga G, Montesano T, Travascio L, Verrienti A, Bruno R, Santini S, D'Arcangelo P, Dallapiccola B, Filetti S, Trischitta V. Torlontano M, et al. Among authors: durante c. J Clin Endocrinol Metab. 2008 Mar;93(3):910-3. doi: 10.1210/jc.2007-1067. Epub 2007 Dec 11. J Clin Endocrinol Metab. 2008. PMID: 18073314
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization.
Castellone MD, Verrienti A, Magendra Rao D, Sponziello M, Fabbro D, Muthu M, Durante C, Maranghi M, Damante G, Pizzolitto S, Costante G, Russo D, Santoro M, Filetti S. Castellone MD, et al. Among authors: durante c. Clin Endocrinol (Oxf). 2010 Oct;73(4):529-34. doi: 10.1111/j.1365-2265.2009.03757.x. Clin Endocrinol (Oxf). 2010. PMID: 20039896
Growth factor receptors gene expression and Akt phosphorylation in benign human thyroid nodules are unaffected by chronic thyrotropin suppression.
Sponziello ML, Bruno R, Durante C, D'Agostino M, Corradino R, Giannasio P, Ciociola E, Ferretti E, Maranghi M, Verrienti A, De Toma G, Filetti S, Russo D. Sponziello ML, et al. Among authors: durante c. Horm Metab Res. 2011 Jan;43(1):22-5. doi: 10.1055/s-0030-1265226. Epub 2010 Sep 30. Horm Metab Res. 2011. PMID: 20886414
XL184 (cabozantinib) for medullary thyroid carcinoma.
Durante C, Russo D, Verrienti A, Filetti S. Durante C, et al. Expert Opin Investig Drugs. 2011 Mar;20(3):407-413. doi: 10.1517/13543784.2011.559163. Expert Opin Investig Drugs. 2011. PMID: 21314233 Review.
308 results